Development of a high specific activity sulfur-35-labeled sulfonamide radioligand that allowed the identification of a new growth hormone secretagogue receptor.
Dean
D C
DC
Department of Drug Metabolism, Merck Research Laboratories, Merck & Co., Rahway, New Jersey 07065, USA.
Nargund
R P
RP
Pong
S S
SS
Chaung
L Y
LY
Griffin
P
P
Melillo
D G
DG
Ellsworth
R L
RL
Van der Ploeg
L H
LH
Patchett
A A
AA
Smith
R G
RG
D000595:Amino Acid Sequence; D000818:Animals; D007211:Indoles / Q000378:metabolism; D008969:Molecular Sequence Data; D011869:Radioligand Assay; D051381:Rats; D011986:Receptors, Somatotropin / Q000378:metabolism*; D013141:Spiro Compounds / Q000378:metabolism; D013449:Sulfonamides / Q000378:metabolism*; D013462:Sulfur Radioisotopes
D007211:Indoles; D011986:Receptors, Somatotropin; D013141:Spiro Compounds; D013449:Sulfonamides; D013462:Sulfur Radioisotopes; C094817:ibutamoren mesylate